Library

A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.

1 May 2023. doid: 10.1002/mds.29360

den Heijer JM, Cullen VC, Pereira DR, Yavuz Y, de Kam ML, Grievink HW, Moerland M, Leymarie N, Khatri K, Sollomoni I, Spitalny L, Dungeon L, Hilt DC, Justman C, Lansbury P, Groeneveld GJ

View publication

Molecules related to glucocerebrosidase (GCase) are potential biomarkers for development of compounds targeting GBA1-associated Parkinson's disease (GBA-PD).

Advancing the boundaries of clinical drug development

Wondering how we can help you? Reach out to us.

Get in contact
contact